 The aim of this prospective, randomized, controlled study is to investigate the effect of pretreatment with intravenous Alprostadil on the incidence of CIN in a high-risk population of patients with both type 2 diabetes mellitus T2DM and CKD undergoing coronary angiography, and evaluate the influence of such potential benefit on short-term outcome. 